Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andrea A. Osypuk"'
Autor:
Adrie van Bokhoven, Howard Li, Erin L. Schenk, Amber M. Johnson, Andrea Abeyta Osypuk, Terry L. Ng, Elena W Y Hsieh, Raphael A. Nemenoff, D. Ross Camidge
Publikováno v:
Journal of Thoracic Oncology. 16:486-491
Introduction Symptomatic early onset pulmonary events (EOPEs) were observed in 3% to 6% of patients within 1 week of starting brigatinib at 90 mg daily for 7 days followed by 180 mg daily. We conducted a prospective observational cohort study to meas
Autor:
Andrea Abeyta Osypuk, Kimberly R. Jordan, Elena W Y Hsieh, Anna Tram Anh Nguyen, Adrie van Bokhoven, Erin L. Schenk, Derek E. Smith, Amber M. Johnson, D. Ross Camidge, Terry L. Ng, Nicole Conti
Publikováno v:
Journal of Clinical Oncology. 38:9538-9538
9538 Background: Phase I-III studies reported symptomatic pulmonary toxicity within the first week of initiating brigatinib in 6% patients post-crizotinib and 3% in TKI naive patients with standard dosing (90mg QD for 7 days then 180mg QD as tolerate
Autor:
Georg Deutsch, Alisa Stephens, Robert Dayton, Carol S. North, Frank F. Tu, Yanli Wang, Nancy Robinson, Gerald L. Andriole, Susan K. Lutgendorf, Yi Luo, Karen R. Jonscher, Clara Grayhack, Wei Yang, Jeffry R. Alger, Eric Ichesco, Jennifer T. Anger, Ted Barrell, Holly T. Sullivan, Fornessa Randal, Lisa A. Kilpatrick, Theresa Spitznagle, Jean Michniewicz, J. Quentin Clemens, Noorulain Noor, John T. Farrar, Jeena Cha, Philip M. Hanno, Kevin A. Johnson, Rebecca L. Bristol, Siobhan Sutcliffe, Claire C. Yang, Jane L. Miller, Katherine A. Scott, Garth D. Ehrlich, Stephanie Richey, Michel A. Pontari, Xingmei Wang, Susan O. Ross, Rebecca McCue, Sandra H. Berry, Monisha Sachdev, Laura Gallagher, M. Scott Lucia, TJ Sundsvold, Sean Mackey, Daniel J. Clauw, David Cella, Kelly Robertson, Tamara Bavendam, Jason J. Kutch, Mary Eno, Michael A. O’Donnell, Nuwanthi Heendeniya, Rachel R. Moericke, Ben Ellingson, Robert M. Moldwin, John W. Kusek, John N. Krieger, Epifanio Bagarinao, Suzanne R. Smith, Graham A. Colditz, David J. Klumpp, Barbara Ziegler, Vincent Funari, Karl J. Kreder, Eric Strachan, Thomas Jemielita, Barry A. Hong, Bruce D. Naliboff, H. Henry Lai, Lauren C. Foster, Richard E. Harris, Steve Harte, Keith R. Solomon, Niloofar Afari, Catherine S. Bradley, J. Richard Landis, Ro Pauline Doe, David R. Williams, Thomas M. Hooton, Ann Oldendorf, Alisa J. Stephens-Shields, Hanno Steen, A. Nilakantan, Sandra Smith, Emily Hubbard, Todd B. Parrish, Cody Ashe-McNalley, Dedra Buchwald, Vivien Gardner, Darlene S. Marko, Roberta Spiro, Kris Greiner, Richard Gershon, Chris Mullins, James W. Griffith, Robert W. Gereau, Michael F. Freeman, Apkar Vania Apkarian, Suzie As-Sanie, Anthony J. Schaeffer, Megan E. Halvorson, Emeran A. Mayer, John W. Froehlich, Timothy J. Ness, Andrew C. Briscoe, Colleen Fitzgerald, Jennifer S. Labus, R. Storey Wilson, Tamara Howard, Charles J. Heckman, M. C. Jiang, Melissa A. Farmer, Karyn S. Eilber, David Briscoe, Marsha A. Moses, Xiaoling Hou, Cara Kulbacki, Richard S. Lee, Katherine T. Martucci, J. Curtis Nickel, Larissa V. Rodriguez, Jeffrey P. Henderson, Jayoung Kim, Andrea A. Osypuk, Jennifer Van Eyk, Ziya Kirkali, Adrie van Bokhoven, Laurie Keefer, Adam S. Curatolo
We examined symptom variability in men and women with urological chronic pelvic pain syndrome. We describe symptom fluctuations as related to early symptom regression and its effect on estimated 1-year symptom change. We also describe a method to qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a50d7919c85782f2e546fac64ed54fb
https://europepmc.org/articles/PMC5069105/
https://europepmc.org/articles/PMC5069105/